Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

FHTXFHTX
Showing 6 of 14 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in FOGHORN THERAPEUTICS INC

CITADEL ADVISORS LLC holds 158,822 shares of FHTX (FOGHORN THERAPEUTICS INC), worth $775,051 as of 2026-Q2. The position was decreased (-20.6% shares). FHTX represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$775,051

Current Shares

158,822

Total Value Change

+$19,042

Total Shares Change

+77,618

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
158,822
-20.6%
$775,0510.0%$4.88
0
2026-Q1
Increased
200,013
+9.7%
$956,0620.0%$5.52
27
2025-Q4
Increased
182,276
+1415.6%
$984,2910.0%$5.15
40
2025-Q3
New
12,027
-
$58,8120.0%$5.01
32
2024-Q4
Exited
0
-100.0%
$00.0%$4.61
0
2024-Q3
Increased
81,204
+25.2%
$756,0090.0%$9.36
30

Other major holders of FHTX: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used